BIOCRYST PHARMACEUTICALS INC (BCRX)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jon P. Stonehouse Former President and Chief Executive Officer | 2025 | $728,466 | $0 | $0 | $11,132,458 | $1,052,633 | $37,525 | $12,951,082 |
| 2024 | $705,536 | $0 | $2,675,919 | $4,002,134 | $899,558 | $34,139 | $8,317,286 | |
| 2023 | $665,600 | $0 | $819,825 | $2,724,624 | $537,472 | $30,257 | $4,777,778 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Charles K. Gayer President and Chief Executive Officer; Former Chief Commercial Officer | 2025 | $609,397 | $0 | $3,358,230 | $4,893,653 | $749,088 | $17,500 | $9,627,868 |
| 2024 | $544,830 | $0 | $930,771 | $1,392,012 | $490,347 | $17,250 | $3,375,210 | |
| 2023 | $495,300 | $0 | $218,620 | $725,803 | $282,321 | $16,500 | $1,738,544 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Babar Ghias Chief Financial Officer | 2025 | $271,515 | $160,000 | $2,124,571 | $3,675,166 | $506,400 | $10,500 | $6,748,152 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Alane P. Barnes Chief Legal Officer and Corporate Secretary | 2025 | $542,519 | $0 | $867,721 | $3,634,923 | $553,369 | $17,500 | $5,616,032 |
| 2024 | $525,442 | $0 | $891,973 | $1,334,133 | $472,898 | $17,250 | $3,241,696 | |
| 2023 | $495,700 | $0 | $411,520 | $725,803 | $282,549 | $16,500 | $1,932,072 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Helen M. Thackray, M.D. Former Chief R&D Officer | 2025 | $425,999 | $0 | $1,168,791 | $1,255,458 | $756,112 | $733,264 | $4,339,624 |
| 2024 | $599,423 | $0 | $930,771 | $1,392,012 | $629,394 | $17,250 | $3,568,850 | |
| 2023 | $576,368 | $0 | $327,930 | $1,089,850 | $383,285 | $16,500 | $2,393,933 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Anthony J. Doyle Former Chief Financial Officer and Treasurer | 2025 | $151,925 | $0 | $708,694 | $1,165,816 | $0 | $114,700 | $2,141,135 |
| 2024 | $549,429 | $0 | $891,973 | $1,334,133 | $494,486 | $17,250 | $3,287,271 | |
| 2023 | $528,297 | $0 | $218,620 | $725,803 | $301,129 | $16,500 | $1,790,349 |